Innovation Pharmaceuticals Inc (IPIX)

[Yooper61]

Your argument supports the justification of their $450k compensation (which I’ll address in another post), not whether it should be in cash or stock. As a long time shareholder, who has gotten in too early trusting in Leo’s PR’s, I would feel better knowing that they were being paid in stock. If I were in their shoes, knowing the potential of “nearly 20 CDA’s” and two non-binding term sheets, taking stock in stead of cash (at least in part) would benefit them and the shareholders.

By the way, if improving the mfg process of B is an accomplishment, what do you call spending $1M on bulk mfg of B over a year ago?